- Home
- Companies
- canada alberta
- disease patient
Show results for
Refine by
Disease Patient Suppliers Serving Alberta
138 companies found
based inBerlin, GERMANY
TIB Molbiol is a medium-sized biotech company who has supplied the global market for over 30 years with reagents for research and medical diagnostics. We are known for our innovation, product quality, design and time to market. Our customers are ...
based inDeerfield, ILLINOIS (USA)
Baxter was founded in 1931, however our history doesn't have one starting point. Our commitment to addressing unmet needs was built on the shoulders of healthcare pioneers whose work resulted in first-of-its-kind innovations in IVs, renal care, ...
HDx enabled by THERANOVA is a new dialysis therapy we are pioneering for patients with end-stage renal disease. The THERANOVA dialyzer features an innovative membrane, which provides an expanded hemodialysis therapy ...
based inSan Francisco, CALIFORNIA (USA)
Virgo Surgical Video Solutions provides the leading cloud video capture, management, and artificial intelligence analysis platform for endoscopic medicine. The Virgo platform is used by a range of academic, integrated, and private practice ...
Innovative video-first approach for decentralized clinical trials. Accelerate patient identification, recruitment, and enrollment and scale central ...
based inShanghai, CHINA
RareStone Group is dedicated to building the first rare disease ecosystem in China to improve the lives of patients and families impacted by rare diseases, by bringing the best-in-the-world therapeutic solutions and comprehensive and sustainable ...
based inMarseille Cedex 9, FRANCE
Veracyte, formerly HalioDx, is a global diagnostics company that improves patient care by answering important clinical questions to inform diagnosis and treatment decisions throughout the patient journey in cancer and other diseases. Our ...
Immunoscore® for Rectal Cancer can help identify patients with LARC who are at a low risk of relapse and may be good candidates for organ preservation. Immunoscore® is available through an Innovation Access Program while the company conducts ...
based inAnkara, TURKEY
Neosys is a prominent medical products manufacturer, specializing in the field of arthroscopy. Since our establishment in 2013, we have gained a reputation as a manufacturer with the highest quality standards and integrity. Commitment to Provide ...
based inTel Aviv, ISRAEL
Our story begins with a meeting back in 2011 between the founders, Oren Goldshtein and Dr. Eyal Orion, MD. The two of them identified the existing heart failure management as a clear unmet clinical need and tried to imagine the next stage of ...
based inCambridge, MASSACHUSETTS (USA)
At BlueRock, our mission is to create authentic cellular medicines to reverse devastating diseases, with the vision of improving the human condition. Until recently, scientists believed that mature adult cells were permanently locked into their ...
based inNeedham, MASSACHUSETTS (USA)
Invicro is an integral part of the REALM IDx, Inc. group, which aims to accelerate personalized medicine, discover novel therapeutic targets and develop innovative therapeutic technologies for unmet medical needs. As a global research partner to the ...
Invicro is an medical imaging CRO with over 210 scientists, 60+ PhD’s and MD’s and 2100+ qualified imaging centers across the globe. We possess scientific and regulatory expertise, project management scale and operational excellence to ...
based inCanton, MICHIGAN (USA)
In 2006, MMS was created by Dr. Uma Sharma, with a vision to turn a one-person consultancy into a global, data-focused CRO that caters to the unique and often changing needs of sponsors. Years later, with an industry-leading customer satisfaction ...
Experts in data science achieve new levels of insight through real world data (RWD), advanced analytics, and interactive ...
based inMilan, ITALY
Italfarmaco SpA is a private Italian multinational company located in Milan, operating in Italy and abroad in both the pharmaceutical and fine chemical industries through its controlled and/or participated companies. Italfarmaco was establish in ...
based inPlanegg, GERMANY
MorphoSys is a commercial-stage biopharmaceutical company dedicated to the discovery, development, and delivery of innovative cancer medicines. At MorphoSys, our ambition is to redefine how cancer is treated. As a commercial-stage biopharmaceutical ...
Tafasitamab (MOR208) is a humanized FC-modified CD19 targeting immunotherapy in clinical development for the treatment of B cell malignancies. CD19 is broadly expressed on the surface of B cells. It is therefore considered as a potential target for ...
based inVienna, AUSTRIA
We are specialized in biomarker development using blood-circulating microRNAs – evolutionary conserved regulators of gene expression and cell/tissue function. We develop diagnostic algorithms (“signatures”) based on the logic combination of microRNA ...
based inHolytown, UNITED KINGDOM
We are developing safer, less expensive CAR-T products which can target more cancers and save more lives. We do this using our integrated model which drives the development of our products through preclinical testing to the clinic. Our mission is to ...
based inSpringdale, ARKANSAS (USA)
ImmunoVision is proud to be a member of the Erba Diagnostics family, a part of the global ERBA Mannheim Group. Earlier known by the name of IVAX Diagnostics, the company specializes in manufacture and marketing of proprietary diagnostic reagents, ...
The dsDNA antigen is a 2690 bp plasmid purified by alkaline lysis and chromatography. The purification process includes operations to minimize reactivity to antibodies against single-stranded DNA. Use of plasmid DNA in ELISA is an effective method ...
based inTel Aviv, ISRAEL
The volume of human molecular data is growing exponentially, but our analytic capabilities are growing linearly, at best. Humans alone cannot process all this data. What’s needed is a technology capable of digesting, organizing and making sense of ...
The first model to map and compare treatments, patient groups and disease mechanisms. ...
based inCambridge, MASSACHUSETTS (USA)
Founded in 2018 by a team of accomplished scientists with a proven track record in drug discovery and executive leadership in top global biopharmaceutical companies, Regor is a pioneering international biotech company with headquarters in Shanghai, ...
based inHergiswil, SWITZERLAND
BioLingus is a Swiss biotech company spearheading the development of oral (sublingual) delivery of peptides and proteins for chronic diseases and immuno-therapy via our innovative formulation technology. Our company focuses on the development of ...
The Cytokine Stabilisation and Slow Release (CSSR) technology is the "mother" of the BioLingus ...
based inTirat Carmel, ISRAEL
Our mission is to translate the complex signals of the immune system into simple diagnostic insights that transform the way we treat infectious diseases and inflammatory disorders – at the right place and the right time. MeMed’s interdisciplinary ...
We have been collaborating with leading clinicians, scientists and commercial partners around the globe to develop and validate a proprietary set of rapid blood tests with the aim of empowering physicians to tackle some of the most challenging ...
based inBurlington, MASSACHUSETTS (USA)
LeMaitre is a leading global innovator, manufacturer and marketer of devices for the treatment of peripheral vascular disease. We’re proud to provide vascular surgeons with the solutions they need to diagnose and heal their patients. While LeMaitre ...
